Elekta helps build advanced healthcare in Iraq

12/11/2003 4:40 AM EST

ELEKTA HELPS BUILD ADVANCED HEALTHCARE IN IRAQ

Through United Nation's oil-for-food program, which also has been part
of the reconstruction of Iraq, Elekta has been chosen to deliver
complete systems for minimal-invasive stereotactic and functional
neurosurgery to be installed at hospitals in various parts of Iraq. The
delivery, carried out in October and with a value of approx. EUR 4.3 M,
also includes training outside Iraq of both neurosurgeons and service
engineers.

The systems supplied by Elekta will be used for routine as well as
advanced, minimal-invasive brain surgery. Each system includes the
Leksell Stereotactic System®, a three-dimensional localizing and
reference system that provides extremely high precision in the
diagnosing and treatment of such ailments as deep seated brain tumors
and functional disorders. Also included in the system is Leksell
SurgiPlan®, an advanced computer-based planning software which makes it
possible for surgeons to plan and simulate treatment in advance.
Instruments for biopsies and haematoma evacuation are included as well
as generators for stimulation and lesioning in the brain for the
treatment of functional and other disorders in the brain.

"Elekta has an ongoing long term commitment to contribute to the
development of health care in the Middle East and to further spread the
gentler and less invasive treatment methods that is made possible by the
company's products", says Lena Höglund, Elekta's Business Manager
Leksell Stereotactic Neurosurgery Europe and Middle East. "The Iraqi
healthcare system is now in a phase of rapid reconstruction. With
Elekta's equipment, many more Iraqi patients can receive basic as well
as advanced minimally invasive brain surgery that is significantly less
risky than the alternative open brain surgery. We are also looking
forward to continue to contribute to the advancement of the healthcare
system in Iraq."

Leksell Stereotactic System®, which is also a key component in the
Leksell Gamma Knife®, is the world leading equipment for minimal
invasive brain surgery and is used today in more than 1,000 hospitals
around the world.

******
For further information, please contact:
International: Peter Ejemyr, Group VP Corporate Communications, Elekta
AB (publ),
Phone: +46 733 611 000, e-mail:  

United States: Lars Jonsteg, VP Investor Relations North America,
Elekta, USA
Phone: +1 770-670-2419, e-mail:  

About Elekta:
Elekta is a world-leading supplier of advanced and innovative radiation
oncology and neurosurgery solutions and services for precise treatment
of cancer and brain disorders. Elekta's solutions are clinically
effective, cost efficient and gentle to the patient.

For additional information about Elekta, please visit www.elekta.com